Rocket Pharmaceuticals Inc Equity-NMS: RCKT

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Previous close :$5.56
Open :$5.41
Today's high :$5.43
Today's low :$5.1
52W low :$5.1
52W high :$26.98
EPS(TTM): :-2.73
Shares O/S :106.63 M
Market cap :545.95 M

Compare with Other Stocks

Stocks Price 1D PE Market Cap
Rocket Pharmaceuticals Inc $5.12 -0.02% - 545.95M

Frequently Asked Questions

What is the share price of Rocket Pharmaceuticals Inc today?

Rocket Pharmaceuticals Inc (RCKT) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

About Rocket Pharmaceuticals Inc

Rocket Pharmaceuticals, Inc. is a fully integrated, late-stage biotechnology company. The Company is advancing a sustainable pipeline of investigational genetic therapies designed to correct the root cause of complex and rare disorders. Its lentiviral (LV) vector-based gene therapies target hematologic diseases and consist of late-stage programs for Fanconi Anemia, a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer, Leukocyte Adhesion Deficiency-I (LAD-I), a severe pediatric genetic disorder that causes recurrent and life-threatening infections which are frequently fatal, and Pyruvate Kinase Deficiency (PKD), a monogenic red blood cell disorder resulting in increased red cell destruction and mild to life-threatening anemia. It also has two clinical stages and one pre-clinical stage in vivo adeno-associated virus (AAV) programs, including programs for Danon disease, Plakophilin-2 Arrhythmogenic Cardiomyopathy and BAG3 Dilated Cardiomyopathy.